“Prognostic Value And Clinical Impact Of EBV And PDL1 Expression In Classical Hodgkin Lymphoma”. 2023. Journal of Pharmaceutical Negative Results, February, 3461-72. https://doi.org/10.47750/pnr.2023.14.02.406.